PureTech Health plc (OTCMKTS:PTCHF – Get Free Report) was the recipient of a large drop in short interest in January. As of January 15th, there was short interest totaling 33,408 shares, a drop of 15.1% from the December 31st total of 39,338 shares. Based on an average trading volume of 132 shares, the days-to-cover ratio is presently 253.1 days. Based on an average trading volume of 132 shares, the days-to-cover ratio is presently 253.1 days.
PureTech Health Stock Performance
Shares of PTCHF opened at $1.85 on Tuesday. The company’s 50 day simple moving average is $1.71 and its 200-day simple moving average is $1.70. PureTech Health has a 12-month low of $1.27 and a 12-month high of $1.90.
About PureTech Health
PureTech Health PLC (“PureTech”) is a clinical-stage biopharmaceutical company focused on the development of innovative medicines to address serious diseases with high unmet medical need. Founded in 2005 by Daphne Zohar and headquartered in Boston, Massachusetts with operations in both North America and Europe, PureTech applies its proprietary platforms to advance therapeutic candidates across immunology, neuroscience and lymphatic-focused indications.
The company leverages three core technology platforms—immune tolerance, gut-targeted delivery and lymphatic transport—to develop novel molecules designed for enhanced specificity and durability of effect.
Read More
- Five stocks we like better than PureTech Health
- The day the gold market broke
- Forget AI, This Will Be the Next Big Tech Breakthrough
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- Gold’s getting scarce.
- ALERT: Drop these 5 stocks before the market opens tomorrow!
Receive News & Ratings for PureTech Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PureTech Health and related companies with MarketBeat.com's FREE daily email newsletter.
